Bank of New York Mellon Corp Acquires New Position in Ralliant Corporation $RAL

Key Points

• Bank of New York Mellon acquired 688,678 Ralliant shares worth approximately $50.7 million, giving it a 0.62% stake. Other institutional investors also increased or initiated positions in the company.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average price target of $75.70; Ralliant recently exceeded quarterly EPS expectations, reporting $0.68 versus the $0.63 consensus.
• Ralliant’s CEO and a senior vice president sold shares under pre-arranged Rule 10b5-1 plans. The company also declared a quarterly dividend of $0.05 per share, representing a 0.3% yield.

Bank of New York Mellon Corp acquired a new stake in Ralliant Corporation (NYSE:RAL - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 688,678 shares of the company's stock, valued at approximately $50,707,000. Bank of New York Mellon Corp owned 0.62% of Ralliant at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of RAL. Irenic Capital Management LP boosted its holdings in shares of Ralliant by 424.1% in the 1st quarter. Irenic Capital Management LP now owns 1,740,218 shares of the company's stock valued at $72,376,000 after buying an additional 1,408,176 shares in the last quarter. Rokos Capital Management LLP bought a new position in shares of Ralliant during the 1st quarter worth approximately $42,022,000. California State Teachers Retirement System raised its stake in shares of Ralliant by 23.1% during the 1st quarter. California State Teachers Retirement System now owns 130,822 shares of the company's stock worth $5,441,000 after acquiring an additional 24,591 shares in the last quarter. Fifth Third Bancorp lifted its position in Ralliant by 3,988.0% during the first quarter. Fifth Third Bancorp now owns 32,132 shares of the company's stock valued at $1,336,000 after acquiring an additional 31,346 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Ralliant during the first quarter valued at approximately $3,593,000.

Analyst Ratings Changes

Several equities research analysts have weighed in on RAL shares. Wall Street Zen upgraded shares of Ralliant from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 22nd. Barclays boosted their price target on Ralliant from $52.00 to $67.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 13th. Morgan Stanley upped their price objective on shares of Ralliant from $68.00 to $85.00 and gave the company an "overweight" rating in a report on Tuesday, June 23rd. Vertical Research lowered shares of Ralliant from a "buy" rating to a "hold" rating and set a $65.00 price target on the stock. in a research note on Wednesday, May 27th. Finally, Royal Bank Of Canada raised their price target on shares of Ralliant from $71.00 to $73.00 and gave the stock a "sector perform" rating in a report on Friday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Ralliant presently has a consensus rating of "Moderate Buy" and a consensus target price of $75.70.

Insider Activity at Ralliant

In related news, CEO Tamara S. Newcombe sold 12,936 shares of the business's stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $71.79, for a total transaction of $928,675.44. Following the completion of the sale, the chief executive officer directly owned 251,967 shares in the company, valued at approximately $18,088,710.93. The trade was a 4.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the stock in a transaction on Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the completion of the transaction, the senior vice president directly owned 31,668 shares of the company's stock, valued at approximately $2,280,096. This represents a 16.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.42% of the company's stock.

Ralliant Stock Performance

NYSE RAL opened at $63.44 on Friday. The stock has a market capitalization of $7.02 billion, a price-to-earnings ratio of -5.85, a PEG ratio of 2.37 and a beta of 1.60. The stock has a 50-day moving average of $68.53 and a 200 day moving average of $56.39. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75. Ralliant Corporation has a twelve month low of $37.27 and a twelve month high of $75.41.

Ralliant (NYSE:RAL - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The firm had revenue of $567.80 million for the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Sell-side analysts anticipate that Ralliant Corporation will post 2.87 EPS for the current fiscal year.

Ralliant Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Tuesday, September 8th. Ralliant's payout ratio is -1.84%.

About Ralliant

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

Want to see what other hedge funds are holding RAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ralliant Corporation (NYSE:RAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source